O’Melveny has advised SciNeuro. SciNeuro Pharmaceuticals has completed a US$53 million equity financing round. The funding round was led by LAV and ARCH Venture Partners, with…
SciNeuro Secures US$53 Million in Equity Financing
O’Melveny has advised SciNeuro. SciNeuro Pharmaceuticals has completed a US$53 million equity financing round. The funding round was led by LAV and ARCH Venture Partners, with…